Reaching Populations to Address Disparities in Cancer Care Delivery: Results From a Six-Site Initiative

Authors:
Noël Arring University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Noël Arring in
Current site
Google Scholar
PubMed Close
 DNP, PhD, RN
,
Christopher R. Friese University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Christopher R. Friese in
Current site
Google Scholar
PubMed Close
 PhD, RN, AOCN
,
Bidisha Ghosh University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Bidisha Ghosh in
Current site
Google Scholar
PubMed Close
 MS
,
Marita Titler University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Marita Titler in
Current site
Google Scholar
PubMed Close
 PhD, RN
,
Heidi Hamann University of Arizona Cancer Center, Tucson, Arizona

Search for other papers by Heidi Hamann in
Current site
Google Scholar
PubMed Close
 PhD
,
Sanja Percac-Lima MGH Chelsea HealthCare Center, Chelsea, Massachusetts

Search for other papers by Sanja Percac-Lima in
Current site
Google Scholar
PubMed Close
 MD, PhD, MPH
,
Adrian Sandra Dobs Johns Hopkins Clinical Research Network, Baltimore, Maryland

Search for other papers by Adrian Sandra Dobs in
Current site
Google Scholar
PubMed Close
 MD, MHS
,
Michelle J. Naughton Cancer Control Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Search for other papers by Michelle J. Naughton in
Current site
Google Scholar
PubMed Close
 MPH, PhD
,
Pooja Mishra Georgia Cancer Center for Excellence, Grady Health System, Atlanta, Georgia

Search for other papers by Pooja Mishra in
Current site
Google Scholar
PubMed Close
 MBA, MHA
,
Melissa A. Simon Northwestern University Feinberg School of Medicine, Chicago, Illinois

Search for other papers by Melissa A. Simon in
Current site
Google Scholar
PubMed Close
 MD, MPH
,
Bingxin Chen University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Bingxin Chen in
Current site
Google Scholar
PubMed Close
 MS
,
Electra D. Paskett College of Public Health, The Ohio State University, Columbus, Ohio

Search for other papers by Electra D. Paskett in
Current site
Google Scholar
PubMed Close
 PhD
,
Robert J. Ploutz-Snyder University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Robert J. Ploutz-Snyder in
Current site
Google Scholar
PubMed Close
 PhD, PStat
,
Martha Quinn Center for Managing Chronic Disease, University of Michigan School of Public Health, Ann Arbor, Michigan

Search for other papers by Martha Quinn in
Current site
Google Scholar
PubMed Close
 MPH
, and
Debra L. Barton University of Michigan School of Nursing, Ann Arbor, Michigan

Search for other papers by Debra L. Barton in
Current site
Google Scholar
PubMed Close
 PhD, RN
Volume/Issue:
Volume 21: Issue 5
Online Publication Date:
11 Apr 2023
DOI:
https://doi.org/10.6004/jnccn.2023.7006
Restricted access

Background: Large segments of the US population do not receive quality cancer care due to pervasive and systemic inequities, which can increase morbidity and mortality. Multicomponent, multilevel interventions can address inequities and improve care, but only if they reach communities with suboptimal access. Intervention studies often underenroll individuals from historically excluded groups. Methods: The Alliance to Advance Patient-Centered Cancer Care includes 6 grantees across the United States who implemented unique multicomponent, multilevel intervention programs with common goals of reducing disparities, increasing engagement, and improving the quality of care for targeted populations. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework informed the evaluation efforts across sites. Each Alliance site identified their intended populations, which included underrepresented minorities (eg, Black and Latinx persons), individuals who prefer a language other than English, and rural residents. We evaluated the demographic characteristics of participants to determine program reach. Results: Between 2018 and 2020, a total of 2,390 of 5,309 potentially eligible participants were enrolled across the 6 sites. The proportion of enrolled individuals with selected characteristics included 38% (n=908) Black adults, 24% (n=574) Latinx adults, 19% (n=454) preferring a language other than English, and 30% (n=717) rural residents. The proportion of those enrolled who were the intended population was commensurate to the proportion with desired characteristics in those identified as potentially eligible. Conclusions: The grantees met or exceeded enrollments from their intended populations who have been underserved by quality cancer care into patient-centered intervention programs. Intentional application of recruitment/engagement strategies is needed to reach individuals from historically underserved communities.

Submitted July 27, 2022; final revision received January 10, 2023; accepted for publication February 1, 2023. Published online April 11, 2023.

Disclosures: Dr. Friese has disclosed receiving grant/research support from Merck Foundation and NCCN Foundation/Pfizer. Dr. Paskett has disclosed serving as a principal investigator for Genentech, Pfizer, Merck Foundation, and Guardant Health; and serving on an advisory board for GlaxoSmithKline. The remaining authors have disclosed that they have not received any financial considerations from any person or organization to support the preparation, analysis, results, or discussion of this article.

Funding: Research reported in this publication was supported by the Merck Foundation.

Correspondence: Debra L. Barton, PhD, RN, Office of Research and PhD Programs, University of Michigan School of Nursing, 400 North Ingalls Street, Suite 4320, Ann Arbor, MI 48109-5482. Email: debbartn@umich.edu
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Weinstein JN, Geller A, Negussie Y, et al, eds. Communities in Action: Pathways to Health Equity. National Academies Press; 2017.

  • 2.

    National Cancer Institute. Cancer disparities. Accessed August 28, 2021. Available at: https://www.cancer.gov/about-cancer/understanding/disparities

  • 3.

    Patel MI, Lopez AM, Blackstock W, et al. Cancer disparities and health equity: a policy statement from the American Society of Clinical Oncology. J Clin Oncol 2020;38:3439–3448.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Tucker-Seeley RD. Social determinants of health and disparities in cancer care for Black people in the United States. JCO Oncol Pract 2021;17:261–263.

  • 5.

    Patel MI, Ma Y, Mitchell B, et al. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? Cancer Epidemiol Biomarkers Prev 2015;24:344–349.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    DeSantis CE, Ma J, Goding Sauer A, et al. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 2017;67:439–448.

  • 7.

    Miller KD, Goding Sauer A, Ortiz AP, et al. Cancer statistics for Hispanics/Latinos, 2018. CA Cancer J Clin 2018;68:425–445.

  • 8.

    Regnante JM, Richie NA, Fashoyin-Aje L, et al. US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract 2019;15:e289–299.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Ahaghotu C, Tyler R, Sartor O. African American participation in oncology clinical trials—focus on prostate cancer: Implications, barriers, and potential solutions. Clin Genitourin Cancer 2016;14:105–116.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract 2013;9:267–276.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Duma N, Vera Aguilera J, Paludo J, et al. Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract 2018;14:e1–10.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Nazha B, Mishra M, Pentz R, et al. Enrollment of racial minorities in clinical trials: old problem assumes new urgency in the age of immunotherapy. Am Soc Clin Oncol Educ Book 2019;39:3–10.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Unger JM, Cook E, Tai E, et al. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book 2016;35:185–198.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Holmes DR, Major J, Lyonga DE, et al. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation. Am J Surg 2012;203:415–422.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Fouad MN, Acemgil A, Bae S, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract 2016;12:556–563.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Simonds VW, Wallerstein N, Duran B, et al. Community-based participatory research: its role in future cancer research and public health practice. Prev Chronic Dis 2013;10:E78.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Rapkin BD, Weiss E, Lounsbury D, et al. Reducing disparities in cancer screening and prevention through community-based participatory research partnerships with local libraries: a comprehensive dynamic trial. Am J Community Psychol 2017;60:145–159.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Miller HN, Charleston J, Wu B, et al. Use of electronic recruitment methods in a clinical trial of adults with gout. Clin Trials 2021;18:92–103.

  • 19.

    Wallington SF, Dash C, Sheppard VB, et al. Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 2016;50:111–117.

  • 20.

    Heiney SP, Adams SA, Wells LM, et al. Evaluation of conceptual framework for recruitment of African American patients with breast cancer. Oncol Nurs Forum 2010;37:E160–167.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Ashing-Giwa K, Rosales M. Recruitment and retention strategies of African American and Latina American breast cancer survivors in a longitudinal psycho-oncology study. Oncol Nurs Forum 2012;39:E434–442.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    RE-AIM. Frequently asked questions. Accessed August 29, 2021. Available at: https://re-aim.org/learn/frequently-asked-questions

  • 23.

    RE-AIM. REACH of health behavior interventions. Accessed January 30, 2022. Available at: https://re-aim.org/learn/what-is-re-aim/reach

Copyright:
Copyright © 2023 by the National Comprehensive Cancer Network 2023
Page Numbers:
6
Article Category:
Research Article
Received:
27 Jul 2022
Accepted:
01 Feb 2023
Print Publication Date:
01 May 2023
Online Publication Date:
11 Apr 2023
Keywords:
disparities in cancer care delivery; underrepresented minorities; quality improvement

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 4910 1923 169
PDF Downloads 1680 253 20
EPUB Downloads 0 0 0